Sarah Jackson, MD
Dermatology · New Orleans, LANPI 1790724326
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 68.0% of it on its own, with 40 other manufacturers making up the rest. Reporting peaked in 2019 at $75,853 and has fallen 96.6% since, to $2,557 in 2025. Among dermatology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 846 payments — averaging $197.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$114K
- Galderma Laboratories, L.p.$27K
- Almirall LLC$8K
- VYNE Pharmaceuticals Inc.$5K
- Pfizer$3K
- Merz North America, Inc.$2K
- plus $8K from 35 others
Across 1,205 payments — averaging $1301.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$730K
- Taro Pharmaceuticals USA, Inc.$373K
- Sanofi Pasteur Inc.$161K
- Endo Pharmaceuticals Inc.$140K
- Dermavant Sciences, Inc.$61K
- Almirall LLC$50K
- plus $53K from 5 others
What the payments were for
- Consulting fees$43,81526%
- Speaking & faculty fees$83,35750%
- Travel & lodging$20,64812%
- Food & beverage$19,13211%
- Education$3720%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$167,324 in reported general payments places this provider in the 90th percentile of 189 dermatology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 83 | $1,630 |
| Triamcinolone Acetonide | 136 | $1,055 |
| Clobetasol Propionate | 25 | $967 |
| Metronidazole | 16 | $672 |
| Mupirocin | 84 | $638 |
| Fluorouracil | 11 | $568 |
| Doxycycline Hyclate | 16 | $522 |
| Nystatin | 37 | $452 |
| Finasteride | 40 | $258 |
| ValacyclovirValacyclovir Hcl | 20 | $252 |
| Minoxidil | 12 | $228 |
| Spironolactone | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New Orleans
- William ClaiborneNew Orleans$374K
- Erin BohNew Orleans$277K
- Mara HaseltineNew Orleans$276K
- Julie MermilliodNew Orleans$222K
- Deirdre HooperNew Orleans$144K
- Patricia HickhamNew Orleans$12K
- Stephen KlingerNew Orleans$11K
- Katherine HolcombMetairie$411K
- Blair BuddenLafayette$329K
- Sarah HaydelHouma$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.